Pharm Q4 Material - ATI The Reproductive & Genitourinary Systems Post Quiz

A nurse is caring for a client who is taking combination oral contraceptive ethinyl estradiol and drospirenone and is about to begin taking rifampin to treat tuberculosis. Which of the following instructions should the nurse give the client due to a possible drug interaction? - "Use additional birth control methods." - MY ANSWER - Rifampin can increase the metabolism of oral contraceptives, reducing the effectiveness. Clients who are taking oral contraceptives and rifampin should use additional contraceptive methods to prevent an unwanted pregnancy. Other drugs that can reduce the effects of oral contraceptives include some antifungal agents and anticonvulsants. A nurse is assessing a client who has a new prescription for the combination oral contraceptive ethinyl estradiol and drospirenone. Which of the following findings should the nurse identify as a contraindication to use of this medication? - Smokes half a pack of cigarettes a day - MY ANSWER - Smoking increases the risks of thromboembolic events, hypertension, and cardiovascular disease for clients who are taking combination oral contraceptives, especially for those clients who are older than 35 years. Clients should quit smoking before starting this drug therapy. After administering terbutaline to a client to inhibit preterm labor, the nurse should assess which of the following? - Heart rate - MY ANSWER - Terbutaline can cause tachycardia, chest pain, and palpitations. The nurse should monitor the client's ECG for tachycardia and other dysrhythmias and monitor fetal heart rate and rhythm. A nurse is caring for a client who is about to begin taking cabergoline to treat infertility. The nurse should explain to the client the need to monitor which of the following laboratory values? - Prolactin level - MY ANSWER - Cabergoline inhibits the secretion of prolactin. The provider should monitor prolactin levels to determine the appropriate dosage. A nurse is caring for a client who is about to begin taking finasteride to treat benign prostatic hypertrophy. The nurse should explain to the client the need to monitor which of the following laboratory values? - Prostate-specific antigen (PSA) - MY ANSWER - The nurse should monitor PSA levels at baseline and periodically thereafter. Increases in PSA can indicate prostate cancer. PSA levels should decrease with finasteride therapy A nurse is caring for a client who has a new prescription for transdermal conjugated estrogen and medroxyprogesterone to treat postmenopausal symptoms. The nurse should explain to the client that this drug combination includes which of the following therapeutic effects? (Select all that apply.) - Reduces the risk of ovarian cancer is correct. Drug therapy with an estrogen and progesterone combination reduces the risk of ovarian cancer. However, the use of estrogen alone without progesterone can increase the risks of endometrial and ovarian cancer. Relieves hot flashes is correct. Drug therapy with an estrogen and progesterone combination or estrogen alone reduces hot flashes and the sweating and sleep disturbances they cause. Prevents osteoporosis is correct. Drug therapy with an estrogen and progesterone combination or estrogen alone increases bone density and prevents osteoporosis. Reduces the risk of breast cancer is incorrect. Drug therapy with an estrogen and progesterone combination increases the risk of breast cancer. Clients taking the drug combination should perform self-breast examinations and have mammograms at the recommended intervals. Reduces the risk of thromboembolism is incorrect. Drug therapy with an estrogen and progesterone combination or estrogen alone increases the risk of thromboembolism. Clients taking the drugs should report a swollen calf, erythema of the skin, shortness of breath, slurred speech, headache, or disorientation.